Insider Trading History of Ausiello Dennis A

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Ausiello Dennis A since 2015. This trader's CIK number is 1381994. At the time of last reporting, Ausiello Dennis A was the Director of Alnylam Pharmaceuticals, Inc.. (stock ticker symbol ALNY). Also see all insider trading activities at Alnylam Pharmaceuticals, Inc..


Yearly summary of insider trading at Alnylam Pharmaceuticals, Inc. (ALNY) by Ausiello Dennis A

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 ALNY 0 $0 31,448 $13,751,078 31,448 $4,518,700
2024 ALNY 0 $0 20,250 $5,321,416 20,250 $2,394,258
2023 ALNY 0 $0 0 $0 136 $0
2022 ALNY 0 $0 45,000 $9,900,000 45,000 $3,199,274
2018 ALNY 0 $0 17,117 $2,567,550 17,117 $1,053,636
2017 ALNY 0 $0 20,000 $2,600,000 20,000 $601,800
2015 ALNY 0 $0 13,871 $1,742,803 706 $45,085


Insider trading of Alnylam Pharmaceuticals, Inc. (ALNY) by Ausiello Dennis A

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-08-14 ALNY Option Ex 31,448 143.69 4,518,700
2025-08-14 ALNY Sale 31,448 437.26 13,751,078
2024-08-06 ALNY Option Ex 20,250 118.23 2,394,258
2024-08-06 ALNY Sale 20,250 262.79 5,321,416
2023-02-23 ALNY Option Ex 136 .00 0
2022-11-21 ALNY Option Ex 22,500 71.09 1,599,637
2022-11-21 ALNY Sale 22,500 220.00 4,950,000
2022-11-21 ALNY Option Ex 22,500 71.09 1,599,637
2022-11-21 ALNY Sale 22,500 220.00 4,950,000
2018-03-13 ALNY Option Ex 17,117 61.55 1,053,636
2018-03-13 ALNY Sale 17,117 150.00 2,567,550
2017-11-02 ALNY Option Ex 20,000 30.09 601,800
2017-11-02 ALNY Sale 20,000 130.00 2,600,000
2015-04-21 ALNY Sale 8,165 130.02 1,061,613
2015-03-19 ALNY Sale 5,000 120.00 600,000
2015-03-05 ALNY Option Ex 706 63.86 45,085
2015-03-05 ALNY Sale 706 115.00 81,190

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ausiello Dennis A (Director of Alnylam Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.